Bloomberg Government recognizes Chamber Hill Strategies as a top-performing lobbying firm out of 2,095 registered lobbying firms in 2020.
Bell Provides Insight into the New Congress, Administration
Jennifer Bell, founding partner, provided political context for and strategic insights into “The Biden Administration, the 117 Congress, and What We Might See in Healthcare” at the Society of Hospital Medicine Annual Meeting.
Bell: What to Expect in 2021
Check out the latest video interview from the National Association of Elder Law Attorneys’ Federal Advocacy Committee co-chairs with Jennifer Bell of Chamber Hill Strategies and NAELA’s Director of Advocacy, David M. Goldfarb, on what members can expect inside the beltway in 2021; how NAELA navigated advocacy during the COVID-19 crisis; and more!
Bell Talks Rx Pricing Reform
In part two of A&M Healthcare Industry Group’s podcast series, Jennifer Bell, Founding Partner of Chamber Hill Strategies and Dr. David Shulkin, Ninth Secretary, U.S. Department of Veterans Affairs, continued their discussion with Peter Urbanowicz, A&M’s Healthcare Industry Group Co-Head, on the Biden Administration’s impact on healthcare policy by focusing on President Biden’s campaign promises for healthcare and how and when they may come to fruition. They also discussed the important issue of prescription drug pricing reform and how we can anticipate the Biden Administration and Congress may deal with the issue.
Bell Previews Impact of the New Administration on Healthcare Policy
A&M’s Healthcare Industry Group Co-Head, Peter Urbanowicz, is joined by Dr. David Shulkin, Ninth Secretary of the U.S. Department of Veterans Affairs and Jennifer Bell, Founding Partner of Chamber Hill Strategies, as they discussed and share perspectives on what the Healthcare landscape and future look like under the Biden Administration.
In part one, Dr. Shulkin and Ms. Bell discussed the role of the cabinet secretary and how the White House and cabinet agencies shape healthcare policy. They also discussed the latest $1.9 trillion COVID-19 stimulus bill and how the bill will affect the ACA Exchanges and Medicaid. And, with Democrats holding the Presidency and both Houses of Congress right now, our experts also weigh in on what the future of federal healthcare policy looks like over the next four years.
Tarazi, Non-Profit Specialist, Joins Chamber Hill Strategies
Chamber Hill Strategies has hired Deema Tarazi as a senior associate. She was previously a lobbyist for March of Dimes and plans to register to lobby in her new role as well, according to the firm.
Bell Discusses Drug Pricing and 340B Outlook for 2021
Jennifer Bell, founding partner, previewed what 2021 looks like for drug pricing, 340B, and oncology care at the annual meeting of the Association of Cancer Executives.
Democratic Strategist Gonzalez Heads to Chamber Hill Strategies
Ariel Gonzalez is joining Chamber Hill Strategies as a principal. He most recently was head of government affairs for March of Dimes, and is an AARP alum.
Gonzalez Leaves March of Dimes for Chamber Hill Strategies
Chamber Hill has hired Ariel Gonzalez as a principal and leading Democrat for the firm. He was most recently senior vice president of public policy and government relations for the March of Dimes.
Bell Named Top Lobbyist in 2020
Jennifer Bell, Chamber Hill Strategies, was named Top Lobbyist in the Hired Gun category.
Chamber Hill Strategies Recognized as a Top-Performer
Bloomberg Government recognizes Chamber Hill Strategies as a top-performing lobbying firm out of 2,139 registered lobbying firms in 2019.